Norgesic

Norgesic ; ; ; ; ; ; ;
Routes	Oral ; ; ; ; ; ;
Identifiers
CAS Number	509146-28-5 ; ; ; ; ; ; ; ; ; ; ; ; ;

Norgesic is the brand name of a muscle relaxant produced by Medicis Pharmaceutical (currently Valeant Pharmaceuticals). The generic is a combination of 385 mg of paracetamol, 25 mg of orphenadrine citrate^[1] and 30 mg of caffeine.^[2]

It was discontinued in the United States by the Food and Drug Administration in October 2015^[3] but is still available in Scandinavia, Austria, Greece, Thailand, Australia and Hong Kong. citation needed ^{(September 2016)}

References[edit]

↑ Norgesic(link).
↑ , Back Pain: A Guide for the Primary Care Physician, Versa Press, 2005, ISBN 1-930513-59-3,
↑ Determination That TENSILON and TENSILON Preservative Free (Edrophonium Chloride) Injectable and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness(link). Food and Drug Administration, Federal Register Volume 80, # 210.2015-10-30.Accessed 2017-08-26.

This drug article relating to the musculoskeletal system is a stub. You can help WikiMD by expanding the page.

Navigation-> Medicine - Wellness - Encyclopedia - Health topics - Diseases - Drugs - Gray's Anatomy - W8MD diet - Ketogenic diet - Recipes

Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Translate page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

[1] Norgesic(link).

[2] , Back Pain: A Guide for the Primary Care Physician, Versa Press, 2005, ISBN 1-930513-59-3,

[3] Determination That TENSILON and TENSILON Preservative Free (Edrophonium Chloride) Injectable and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness(link). Food and Drug Administration, Federal Register Volume 80, # 210.2015-10-30.Accessed 2017-08-26.

[1]

[2]

[3]